Market Capitalization

At a key summit, Candel Therapeutics will showcase how its oncolytic virus, CAN-3110, uses biomarkers to fight one of the deadliest brain cancers.

HeartCore Enterprises forecasts a dramatic swing to profitability in 2025 after divesting its software unit, betting its future on IPO consulting.

Financially robust and debt-free, Rail Vision is rapidly expanding its AI safety systems globally while a new quantum computing arm aims to redefine the future of rail.

Terex declared a steady dividend, but the real story is its surging stock and a bold forecast, revealing deep confidence in its strategic direction.

With a massive French state-guaranteed financing, Eutelsat is funding a new fleet of 340 Airbus satellites to secure OneWeb's future in the LEO race.

Capitol AI appoints Chester Leung as VP of Engineering, signaling a major push to embed security and governance at the core of its enterprise platform.

Celebrating 30 years, Topband's journey from a local supplier to a global intelligent solutions giant mirrors China's industrial evolution.

Investors await Alkane's H1 results for insights on its post-merger performance, Boda-Kaiser project, and standing in a surging commodities market.

The Baltic real estate giant divests a key Latvian asset at a profit, unlocking millions in capital for new investments and signaling a hot logistics market.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

Fresh off its Nasdaq debut, adtech firm EVA Live is betting on its new NeuroServer AI, shelving a stock sale and eyeing a buyback to fuel growth.

Klinikum Fürth becomes the first hospital in Germany to use Stereotaxis's Genesis robot, offering new precision and safety for heart arrhythmia patients.

Swvl's new healthcare mobility contract in Saudi Arabia marks a strategic shift to high-value enterprise deals. Can this move stabilize the firm?

The record $70 million sale of AI.com to Crypto.com's CEO signals a new era for digital assets, where a domain name can define an entire industry.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

The legal tech firm is cleared for trading after a two-month halt, now focusing on debt reduction using proceeds from a major UK asset divestiture.

Key Mining Corp. is going public via a SPAC deal to fund a massive titanium project in Chile, betting on rising demand for critical minerals.